- Home
- PROK vs PETS Comparison
PROK vs PETS Comparison
Compare PROK & PETS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PROK
- PETS
- Stock Information
- Founded
- PROK 2015
- PETS 1996
- Country
- PROK United States
- PETS United States
- Employees
- PROK N/A
- PETS N/A
- Industry
- PROK Biotechnology: Biological Products (No Diagnostic Substances)
- PETS Retail-Drug Stores and Proprietary Stores
- Sector
- PROK Health Care
- PETS Consumer Staples
- Exchange
- PROK Nasdaq
- PETS Nasdaq
- Market Cap
- PROK 126.8M
- PETS 105.6M
- IPO Year
- PROK N/A
- PETS N/A
- Fundamental
- Price
- PROK $0.84
- PETS $4.00
- Analyst Decision
- PROK Buy
- PETS Sell
- Analyst Count
- PROK 4
- PETS 2
- Target Price
- PROK $5.00
- PETS $3.50
- AVG Volume (30 Days)
- PROK 434.6K
- PETS 194.7K
- Earning Date
- PROK 05-09-2025
- PETS 02-10-2025
- Dividend Yield
- PROK N/A
- PETS N/A
- EPS Growth
- PROK N/A
- PETS N/A
- EPS
- PROK N/A
- PETS 0.02
- Revenue
- PROK $76,000.00
- PETS $247,010,000.00
- Revenue This Year
- PROK N/A
- PETS N/A
- Revenue Next Year
- PROK N/A
- PETS N/A
- P/E Ratio
- PROK N/A
- PETS $235.58
- Revenue Growth
- PROK N/A
- PETS N/A
- 52 Week Low
- PROK $0.80
- PETS $2.90
- 52 Week High
- PROK $4.44
- PETS $6.85
- Technical
- Relative Strength Index (RSI)
- PROK 29.40
- PETS 41.52
- Support Level
- PROK $0.87
- PETS $4.02
- Resistance Level
- PROK $1.00
- PETS $4.28
- Average True Range (ATR)
- PROK 0.10
- PETS 0.16
- MACD
- PROK 0.01
- PETS 0.02
- Stochastic Oscillator
- PROK 14.70
- PETS 22.22
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's own cells isolated from the patient intended for treatment. Its lead product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's own renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of development program for severe diabetic kidney disease.
About PETS PetMed Express Inc.
PetMed Express Inc along with its subsidiaries is a nationwide pet pharmacy. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The company generates its revenue by selling pet medications and pet supplies mainly to retail consumers.